About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Clinical Trials in Washington | 25,885 Studies Near You

Clinical TrialsWashington

Clinical Trials in Washington

Discover 25,885 clinical trials near Washington. Find research studies in your area.

Browse by condition:

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma Pancreatic Cancer

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 5721-5740 of 25,885 trials

TerminatedEpidural Contrast Flow Patterns of TESI Using the Inferior-Anterior Position as the Final Needle Tip Position.The purpose of this study is to describe the contrast flow patterns in the epidural space using the inferior-anterior approach with continuous fluoroscopic guidance, and determine…NCT01836770·Washington D.C., District of Columbia TerminatedEfficacy and Safety of Losmapimod in Treating Participants With Facioscapulohumeral Muscular Dystrophy (FSHD) (REACH)This is a study to evaluate the safety and efficacy of losmapimod in treating participants with Facioscapulohumeral Muscular Dystrophy (FSHD).NCT05397470·Irvine, California and 32 others

Find Trials by Condition in Washington

Breast Cancerin Washington Lung Cancerin Washington Prostate Cancerin Washington Colorectal Cancerin Washington Melanomain Washington Leukemiain Washington Lymphomain Washington Pancreatic Cancerin Washington Ovarian Cancerin Washington Brain Cancerin Washington

Data from ClinicalTrials.govTerms

CompletedPreterm Erythropoietin Neuroprotection Trial (PENUT Trial)Recombinant human erythropoietin (Epo) is a promising novel neuroprotective agent.NCT01378273·Little Rock, Arkansas and 18 others

TerminatedTreatment of Adenoviral Conjunctivitis With SHP640 Compared to PlaceboThe purpose of this study is to determine if an investigational treatment is effective compared with placebo in the treatment of adults and children with adenoviral conjunctivitis.NCT02998554·Glendale, California and 30 others

CompletedAnemia Studies in Chronic Kidney Disease: Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor Daprodustat-Dialysis (ASCEND-D)The purpose of this multi-center event-driven study in participants with anemia associated with chronic kidney disease (CKD) to evaluate the safety and efficacy of daprodustat.NCT02879305·Huntsville, Alabama and 461 others

CompletedStudy of the Efficacy and Safety of the Ranibizumab Port Delivery System for Sustained Delivery of Ranibizumab in Patients With Subfoveal Neovascular Age-Related Macular DegenerationThis is a Phase II multicenter, dose-ranging, randomized, active treatment (monthly ITV injection)-controlled study to evaluate the efficacy, safety, and pharmacokinetics of…NCT02510794·Mesa, Arizona and 49 others

CompletedA Pilot Study of Allopurinol As A Modifier of 6-MP Metabolism in Pediatric ALLThis research is being done to determine if allopurinol can change the metabolism of the oral chemotherapeutic medication 6-mercaptopurine (6-MP) in children with acute…NCT02046694·Baltimore, Maryland and 2 others

CompletedThe GUARD Trial - Part 1: A Phase 3 Clinical Trial for Prevention of Proliferative VitreoretinopathyThe GUARD Trial is a multi-center, randomized, controlled, adaptive Phase 3 clinical trial of repeated intravitreal injections of ADX-2191 versus standard-of-care for the…NCT04136366·Phoenix, Arizona and 22 others

Active not recruitingAn Open-label Study of JSB462 (Luxdegalutamide) in Combination With Abiraterone in Adult Male Patients With Metastatic Hormone-sensitive Prostate Cancer (mHSPC)This Phase II study aims to evaluate efficacy and safety of the combination of JSB462 (also known as luxdegalutamide) at 100 mg and 300 mg once a day (QD) doses + abiraterone…NCT06991556·La Jolla, California and 64 others

CompletedTachoSil® Versus Surgicel® Original for the Secondary Treatment of Local Bleeding in Adult and Pediatric Patients Undergoing Hepatic Resection SurgeryThe efficacy and safety of TachoSil® as secondary hemostatic treatment in hepatic resection surgery will be compared to the standard USA licensed hemostatic agent, Surgicel®…NCT01192022·Los Angeles, California and 16 others

CompletedInterstitial CystitisPatients with interstitial cystitis who meet eligibility requirements will be randomized to one of four treatment arms (3 RTX, Placebo).NCT00056251·Anchorage, Alaska and 23 others

CompletedStudy of Human Anti-TNF Monoclonal Antibody D2E7 in Subjects With Active Rheumatoid ArthritisThe purpose of the study is to evaluate safety by collecting serious adverse events in subjects with moderately to severely active rheumatoid arthritis who are unable to obtain…NCT00049751·Mobile, Alabama and 53 others

TerminatedStudy To Evaluate The Effect Of Torcetrapib/Atorvastatin In Subjects With A Genetic Cholesterol Disorder.The Torcetrapib project was terminated on December 2, 2006 due to safety findings.NCT00145431·Anaheim, California and 26 others

TerminatedHT-100 Long-term Study in DMD Patients Who Completed HALO-DMD-02This study, HALO-DMD-03, is a follow-on study to HALO-DMD-01 and HALO-DMD-02, and allows continued open-label access to HT-100 for subjects who have completed these studies.NCT02525302·Sacramento, California and 4 others

CompletedAdjuvant Therapy for High-Risk Breast Cancer With Wkly Adriamycin & Oral Cytoxan With G-CSF for 12 Wks; Wkly Taxol x 12The primary objectives of the study are to evaluate the feasibility and toxicity of treatment with 12 weeks of Adriamycin with daily oral Cytoxan with G-CSF support followed by 12…NCT00194753·Seattle, Washington

Active not recruitingALTUS: Performance of a Multi- Target Hepatocellular Carcinoma (HCC) Test in Subjects With Increased RiskThe primary objective is to assess overall sensitivity and specificity of Oncoguard™ Liver for hepatocellular cancer (HCC) detection in a surveillance population.NCT05064553·Chandler, Arizona and 75 others

CompletedSeroprevalence of Hepatitis E in People With an Organ TransplantBackground: \- The hepatitis E virus causes an acute hepatitis that usually goes away by itself. Researchers in France studied people who received a liver or kidney transplant.NCT02190253·Washington D.C., District of Columbia and 2 others

CompletedA Phase I Safety and Immunogenicity Trial of UBI HIV Lipopeptide Vaccine Component P3C541b in HIV-1 Seronegative Human SubjectsTo evaluate an HIV synthetic lipopeptide candidate vaccine component, P3C541b, at two dose levels, administered subcutaneously (s.c.) in a randomized, double-blind, placebo…NCT00000845·Baltimore, Maryland and 2 others

CompletedPhase 3 Study With Ciprofloxacin Dispersion for Inhalation in Non-CF Bronchiectasis (ORBIT-4)This study (ARD-3150-1202, ORBIT-4) will evaluate the safety and efficacy of inhaled Pulmaquin (ciprofloxacin dispersion for inhalation) compared to inhaled placebo in subjects…NCT02104245·Phoenix, Arizona and 94 others

CompletedTroVax Renal Immunotherapy Survival TrialThe purpose of this study is to investigate whether TroVax, when added to first line standard of care therapy, improves survival for patients with locally advanced or metastatic…NCT00397345·Tucson, Arizona and 151 others

PreviousPage 287 of 1295Next

Diabetes

in Washington

Heart Diseasein Washington